Overview

Altitude Sickness Prevention With Ibuprofen Relative to Acetazolamide and Treatment Efficacy

Status:
Completed
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
This double blind randomized trial will compare ibuprofen to acetazolamide for the prevention of acute mountain sickness. These drugs have never been directly compared for efficacy. The study population is hikers who are ascending at their own rate under their own power in a true hiking environment at the White Mountain Research Station, Owen Valley Lab (OVL) and Bancroft Station (BAR), Bancroft Peak, White Mountain, California.
Phase:
Phase 1
Details
Lead Sponsor:
Grant S Lipman
Treatments:
Acetazolamide
Ibuprofen